Full name
"BETA-MED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | -0 | -0 | -644,3 |
Gross profit (loss) | -0 | -0 | 0 | 1448,6 |
EBITDA | 0 | 0 | 0,1 | 268,3 |
Short time liabilities | 0,1 | 0,1 | 0,1 | -0,4 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 0,3 | 0,3 | 0,4 | 9,1 |
Operating profit (EBIT) | -0 | -0 | 0 | 80 004 |
Assets | 0,5 | 0,5 | 0,5 | 6,3 |
Net profit (loss) | -0 | -0 | 0 | 1188,9 |
Cash | 0,1 | 0,1 | 0,1 | 68,5 |
Net income from sale | 3 | 3 | 3 | 2,4 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | -0,4 |
Working assets | 0,4 | 0,4 | 0,4 | 17,1 |
Other income costs | 0 | 0 | 0,1 | 1202,2 |
Depreciation | 0 | 0 | 0 | 86,7 |
% | % | % | p.p. | |
Profitability of capital | -0,8 | -0,8 | 8,3 | 9,1 |
Equity capital to total assets | 70,2 | 70,2 | 72 | 1,8 |
Gross profit margin | -0,1 | -0,1 | 1,1 | 1,2 |
EBITDA Margin | 0,6 | 0,6 | 2,3 | 1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 17 | 17 | 17 | 0 |
Current financial liquidity indicator | 2.6970529556274414 | 2.6970529556274414 | 3.1701784133911133 | 0,5 |
Net dept to EBITDA | -2.6735050678253174 | -2.6735050678253174 | -1.863402009010315 | 0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane